RecruitingPhase 2NCT05650229
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Studying Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Abliva AB
- Principal Investigator
- Amel Karaa, MDMassachusetts General Hospital
- Intervention
- KL1333(drug)
- Enrollment
- 180 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2027
Study locations (23)
- Akron Children's Hospital, Akron, Ohio, United States
- The University of Texas Health Science Center at Houston, Houston, Texas, United States
- Hopital Universitaire de Bruxelles (H.U.B)/ Academisch Ziekenhuis Brussel, Brussels, Belgium
- Universitair Ziekenhuis Gent, Ghent, Belgium
- Universitair Ziekenhuis Leuven Gasthuisberg Campus, Leuven, Belgium
- Copenhagen Neuromuscular Center, Rigshospitalet, Copenhagen, Denmark
- Centre Hospitalier Universitaire (CHU) de Bordeaux - Groupe Hospitalier Pellegrin, Bordeaux, France
- Hopital Roger Salengro, CHRU de Lille, Lille, France
- Centre Hospitalier Universitaire de Nice, Hopital Pasteur 2, Nice, France
- CHU de NICE - Hôpital Archet 2, Nice, France
- Groupe Hospitalier Pitie-Salpetriere, Paris, France
- IRCCS Institute of Neurological Sciences of Bologna- Universita di Bologna, Bologna, Italy
- Azienda Ospedaliera Universitaria Gaetano Martino Messina, Messina, Italy
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
- Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
- +8 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05650229 on ClinicalTrials.govOther trials for Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06451757KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial DiseasesKhondrion BV
- RECRUITINGPHASE1NCT05241262Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione LevelsMichio Hirano, MD